Hydroxychloroquine and Azithromycin in COVID 19 should be immediately approved for COVID treatment OR should doctors give it as an off label use |
Clinical News
eMediNexus Coverage from: 
Hydroxychloroquine and Azithromycin in COVID 19 should be immediately approved for COVID treatment OR should doctors give it as an off label use
Dr KK Aggarwal, President CMAAO, HCFI and Past National President IMA,  21 March 2020
Coronavirus Live Count Map India

remove_red_eye 34195 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

23 Read Comments                

Recommended Use: Hydroxychloroquine, 200 mg three times per day for 10 days and Azithromycin, 500 mg once daily for ten daysBoth chloroquine and hydroxychloroquine have been reported to inhibit SARS-CoV-2 in vitro, although hydroxychloroquine appears to have more potent antiviral activity [1].Chloroquine is included in Chinas National Health Commission treatment guidelines. As per available evidence it has been suggested that the drug is associated with the reduced progression of disease and dur...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now